Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Telehealth in rheumatology: From ‘boutique industry’ to ‘unavoidable reality’ Rob Volansky
• AMA adopts policy declaring government intrusion to medicine a violation of human rights Emma Bascom
• AMA: Climate change is a public health crisis Emma Bascom
• FDA approves Amgen’s rituximab biosimilar for treatment of moderate-to-severe RA
• FDA approves Olumiant for certain adults hospitalized with COVID-19
• FDA grants investigational new drug status to BTK inhibitor for immunological disease
• Federal Trade Commission opens investigation into pharmacy benefit managers Erich Martin
• Psoriatic arthritis trials should seek deeper remission states, end placebo controls Erich Martin
• Ustekinumab biosimilar candidate achieves ‘therapeutic equivalence’
• Telemedicine and rheumatology: Where is empathy in the digital encounter? Leonard H. Calabrese, DO
• COVID-19 Global Rheumatology Alliance registry to close after leaving ‘enormous impact’ Erich Martin
• Q&A: Body image concerns in lupus leave patients feeling ‘betrayed,’ ‘out of control’ Erich Martin
• Q&A: Non-criteria manifestations of pediatric APS common yet ‘under-recognized’ Rob Volansky
• Though still used, glucocorticoid treatments ‘should be avoided’ in patients with RA David Statman
• Hooked on Rheum with Arthur Kavanaugh, MD Arthur Kavanaugh, MD
• EULAR: Routine, proactive therapeutic drug monitoring unnecessary in RMDs Erich Martin
• Insurance delays in juvenile arthritis not impacted by private, public coverage Erich Martin
• Mobility restriction in ankylosing spondylitis occurs mainly in early years of disease Erich Martin
• Steroids may reduce risk for death after severe COVID-19 hospitalization Erich Martin
• COVID-19 mRNA vaccines ‘highly effective’ in immune-mediated inflammatory disease Erich Martin
• Data find ‘direct correlation’ between air pollution and osteoporosis, autoimmune disease Rob Volansky
• Empathy holds ‘great power’ as rheumatologists find role in long COVID management Erich Martin
• High efficiency vs. the personal connection: Experts debate the future of telemedicine Erich Martin
• Impacts of ‘understudied’ calcium pyrophosphate deposition remain unknown Rob Volansky
• ‘More than half’ of rheumatology patients reported post-traumatic stress during COVID-19 Rob Volansky
• Patients using antihistamines show decreased structural progression in knee osteoarthritis Erich Martin
• Patients with depression demonstrate six-fold increased mortality risk in RA Erich Martin
• Patients with pediatric dermatomyositis need guidance on disease ‘rollercoaster’ Rob Volansky
• Preterm delivery nearly twice as common in patients with lupus vs. general population Rob Volansky
• Sjögren’s syndrome ‘not curable, but certainly treatable’ with available therapies Rob Volansky
• Specialized physiotherapy may improve sexual health in women with systemic sclerosis Erich Martin
• ‘Split’ decision: JAK inhibitors have delivered on only part of their promise Rob Volansky
• ‘Very exciting’ data: Bimekizumab superior to placebo in psoriatic arthritis Rob Volansky